“Vaccinated against covid will be like flu”

by time news

Binnopharm Group Holding is the first manufacturer of the Sputnik V coronavirus vaccine. Its main shareholder is AFK Sistema Vladimir Yevtushenkov, who has been collecting various pharmaceutical assets since 2018. Today they are merged into Binnopharm Group. Initially, the holding planned to become the leader of the pharmaceutical industry only in Russia, but now it aims higher: the company expects to become the largest player in Eastern Europe. The first steps in this direction have already been taken – the holding’s representative offices are open in six CIS countries. In an interview with Vedomosti, Binnopharm Group CEO Rustem Muratov talks about the timing of the planned IPO and the role of the coronavirus vaccine in the holding’s business.

“We have developed competencies in the field of vaccine production”

We have been living with the coronavirus for two years now. And at every stage of the pandemic, Binnopharm Group was among those who provide the population with drugs. Did you manage to make money on your “anti-currency portfolio”?

– There is no such thing as a “portfolio of anti-covid drugs”, there are drugs recommended in the protocols for the treatment of coronavirus infection and its consequences. How much you can earn on them is a difficult question. After all, look at the recommendations of the Ministry of Health – from version to version, the list of drugs in them changes greatly. Relatively stable there are only a few international generic names, and few can say what drugs we will see there in a year.

You may also like

Leave a Comment